A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
Status:
Completed
Trial end date:
2016-05-30
Target enrollment:
Participant gender:
Summary
The primary objective for this study is to evaluate the safety of lebrikizumab compared with
Topical Corticosteroids (TCS) alone in patients with persistent moderate to severe Atopic
Dermatitis (AD) that is inadequately controlled with TCS.